References
- Adeloye D, Song P, Zhu Y, et al. Global, regional, and national prevalence of, and risk factors for, chronic obstructive pulmonary disease (COPD) in 2019: a systematic review and modelling analysis. Lancet Respir Med. 2022;10(5):447–458. DOI:10.1016/S2213-2600(21)00511-7
- Soriano JB, Kendrick PJ, Paulson KR, et al. Prevalence and attributable health burden of chronic respiratory diseases, 1990–2017: a systematic analysis for the global burden of disease study 2017. Lancet Respir Med. 2020;8(6):585–596.
- Villegas CG, Paz-Zulueta M, Herrero-Montes M, et al. Cost analysis of chronic obstructive pulmonary disease (COPD): a systematic review. Health Econ Rev. 2021;11(1):31. DOI:10.1186/s13561-021-00329-9
- Lipovec NC, Beijers RJ, van den Borst B, et al. The prevalence of metabolic syndrome in chronic obstructive pulmonary disease: a systematic review. COPD. 2016;13(3):399–406. DOI:10.3109/15412555.2016.1140732
- Xuan L, Han F, Gong L, et al. Association between chronic obstructive pulmonary disease and serum lipid levels: a meta-analysis. Lipids Health Dis. 2018;17(1):263. DOI:10.1186/s12944-018-0904-4
- Peng Y, Zhong GC, Wang L, et al. Chronic obstructive pulmonary disease, lung function and risk of type 2 diabetes: a systematic review and meta-analysis of cohort studies. BMC Pulm Med. 2020;20(1):137. DOI:10.1186/s12890-020-1178-y
- Wang JJ. Risk of coronary heart disease in people with chronic obstructive pulmonary disease: a meta-analysis. Int J Chron Obstruct Pulmon Dis. 2021;16:2939–2944. DOI:10.2147/COPD.S331505
- Liu X, Chen Z, Li S, et al. Association of chronic obstructive pulmonary disease with arrhythmia risks: a systematic review and meta-analysis. Front Cardiovasc Med. 2021;8:732349.
- Wang Y, Li X, Wei B, et al. Association between chronic obstructive pulmonary disease and dementia: systematic review and meta-analysis of cohort studies. Dement Geriatr Cogn Dis Extra. 2019;9(2):250–259. DOI:10.1159/000496475
- Sampaio MS, Vieira WA, Bernardino IM, et al. Chronic obstructive pulmonary disease as a risk factor for suicide: a systematic review and meta-analysis. Respir Med. 2019;151:11–18. DOI:10.1016/j.rmed.2019.03.018
- Janssen EM, McGinty EE, Azrin ST, et al. Review of the evidence: prevalence of medical conditions in the United States population with serious mental illness. Gen Hosp Psychiatry. 2015;37(3):199–222. DOI:10.1016/j.genhosppsych.2015.03.004
- Ali S, Santomauro D, Ferrari AJ, et al. Excess mortality in severe mental disorders: a systematic review and meta-regression. J Psychiatr Res. 2022;149:97–105. DOI:10.1016/j.jpsychires.2022.02.036
- Saha S, Chant D, McGrath J. A systematic review of mortality in schizophrenia: is the differential mortality gap worsening over time? Arch Gen Psychiatry. 2007;64(10):1123–1131. DOI:10.1001/archpsyc.64.10.1123
- Hayes JF, Miles J, Walters K, et al. A systematic review and meta-analysis of premature mortality in bipolar affective disorder. Acta Psychiatr Scand. 2015;131(6):417–425. DOI:10.1111/acps.12408
- Dickerson F, Schroeder J, Katsafanas E, et al. Cigarette smoking by patients with serious mental illness, 1999–2016: an increasing disparity. Psychiatr Serv. 2018;69(2):147–153. DOI:10.1176/appi.ps.201700118
- Suetani S, Honarparvar F, Siskind D, et al. Increased rates of respiratory disease in schizophrenia: a systematic review and meta-analysis including 619,214 individuals with schizophrenia and 52,159,551 controls. Schizophr Res. 2021;237:131–140. DOI:10.1016/j.schres.2021.08.022
- Zareifopoulos N, Bellou A, Spiropoulou A, et al. Prevalence of comorbid chronic obstructive pulmonary disease in individuals suffering from schizophrenia and bipolar disorder: a systematic review. COPD. 2018;15(6):612–620. DOI:10.1080/15412555.2019.1572730
- Partti K, Vasankari T, Kanervisto M, et al. Lung function and respiratory diseases in people with psychosis: population-based study. Br J Psychiatry. 2015;207(1):37–45. DOI:10.1192/bjp.bp.113.141937
- Bendayan R, Kraljevic Z, Shaari S, et al. Mapping multimorbidity in individuals with schizophrenia and bipolar disorders: evidence from the South London and Maudsley NHS Foundation Trust Biomedical Research Centre (SLAM BRC) case register. BMJ Open. 2022;12(1):e054414. DOI:10.1136/bmjopen-2021-054414
- Sokal J, Messias E, Dickerson FB, et al. Comorbidity of medical illnesses among adults with serious mental illness who are receiving community psychiatric services. J Nerv Ment Dis. 2004;192(6):421–427. DOI:10.1097/01.nmd.0000130135.78017.96
- Brink M, Green A, Bojesen AB, et al. Excess medical comorbidity and mortality across the lifespan in schizophrenia.: a nationwide danish register study. Schizophr Res. 2019;206:347–354. DOI:10.1016/j.schres.2018.10.020
- Crump C, Winkleby MA, Sundquist K, et al. Comorbidities and mortality in persons with schizophrenia: a Swedish national cohort study. Am J Psychiatry. 2013;170(3):324–333. DOI:10.1176/appi.ajp.2012.12050599
- Hsu JH, Chien IC, Lin CH, et al. Increased risk of chronic obstructive pulmonary disease in patients with schizophrenia: a population-based study. Psychosomatics. 2013;54(4):345–351. DOI:10.1016/j.psym.2012.08.003
- Krieger I, Bitan DT, Comaneshter D, et al. Increased risk of smoking-related illnesses in schizophrenia patients: a nationwide cohort study. Schizophr Res. 2019;212:121–125. DOI:10.1016/j.schres.2019.07.058
- Hsu JH, Chien IC, Lin CH. Increased risk of chronic obstructive pulmonary disease in patients with bipolar disorder: a population-based study. J Affect Disord. 2017;220:43–48. DOI:10.1016/j.jad.2017.05.049
- Crump C, Sundquist K, Winkleby MA, et al. Comorbidities and mortality in bipolar disorder: a swedish national cohort study. JAMA Psychiatry. 2013;70(9):931–939. DOI:10.1001/jamapsychiatry.2013.1394
- Carney CP, Jones L, Woolson RF. Medical comorbidity in women and men with schizophrenia: a population-based controlled study. J Gen Intern Med. 2006;21(11):1133–1137. DOI:10.1111/j.1525-1497.2006.00563.x
- Copeland LA, Mortensen EM, Zeber JE, et al. Pulmonary disease among inpatient decedents: impact of schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 2007;31(3):720–726. DOI:10.1016/j.pnpbp.2007.01.008
- Hetlevik O, Solheim M, Gjesdal S. Use of GP services by patients with schizophrenia: a national cross-sectional register-based study. BMC Health Serv Res. 2015;15:66. DOI:10.1186/s12913-015-0719-1
- Khaykin E, Ford DE, Pronovost PJ, et al. National estimates of adverse events during nonpsychiatric hospitalizations for persons with schizophrenia. Gen Hosp Psychiatry. 2010;32(4):419–425. DOI:10.1016/j.genhosppsych.2010.04.006
- Schoepf D, Uppal H, Potluri R, et al. Physical comorbidity and its relevance on mortality in schizophrenia: a naturalistic 12-year follow-up in general hospital admissions. Eur Arch Psychiatry Clin Neurosci. 2014;264(1):3–28. DOI:10.1007/s00406-013-0436-x
- Carney CP, Jones LE. Medical comorbidity in women and men with bipolar disorders: a population-based controlled study. Psychosom Med. 2006;68(5):684–691. DOI:10.1097/01.psy.0000237316.09601.88
- Schoepf D, Heun R. Comorbid medical illness in bipolar disorder. Br J Psychiatry. 2015;206(6):522–523. DOI:10.1192/bjp.206.6.522a
- Kilbourne AM, Cornelius JR, Han X, et al. Burden of general medical conditions among individuals with bipolar disorder. Bipolar Disord. 2004;6(5):368–373. DOI:10.1111/j.1399-5618.2004.00138.x
- Hendrie HC, Tu W, Tabbey R, et al. Health outcomes and cost of care among older adults with schizophrenia: a 10-year study using medical records across the continuum of care. Am J Geriatr Psychiatry. 2014;22(5):427–436. DOI:10.1016/j.jagp.2012.10.025
- Perugi G, Quaranta G, Belletti S, et al. General medical conditions in 347 bipolar disorder patients: clinical correlates of metabolic and autoimmune-allergic diseases. J Affect Disord. 2015;170:95–103. DOI:10.1016/j.jad.2014.08.052
- Schoepf D, Heun R. Bipolar disorder and comorbidity: increased prevalence and increased relevance of comorbidity for hospital-based mortality during a 12.5-year observation period in general hospital admissions. J Affect Disord. 2014;169:170–178. DOI:10.1016/j.jad.2014.08.025
- Hoerster KD, Lehavot K, Simpson T, et al. Health and health behavior differences: u.S. Military, veteran, and civilian men. Am J Prev Med. 2012;43(5):483–489. DOI:10.1016/j.amepre.2012.07.029
- Lehavot K, Hoerster KD, Nelson KM, et al. Health indicators for military, veteran, and civilian women. Am J Prev Med. 2012;42(5):473–480. DOI:10.1016/j.amepre.2012.01.006
- Hooper R, Burney P, Vollmer WM, et al. Risk factors for COPD spirometrically defined from the lower limit of normal in the BOLD project. Eur Respir J. 2012;39(6):1343–1353. DOI:10.1183/09031936.00002711
- Hernández C, Alonso A, Garcia-Aymerich J, et al. Effectiveness of community-based integrated care in frail COPD patients: a randomised controlled trial. NPJ Prim Care Respir Med. 2015;25:15022.
- Rose L, Istanboulian L, Carriere L, et al. Program of integrated care for patients with chronic obstructive pulmonary disease and multiple comorbidities (PIC COPD(+)): a randomised controlled trial. Eur Respir J. 2018;51(1):1701567. DOI:10.1183/13993003.01567-2017
- Mularski RA, Asch SM, Shrank WH, et al. The quality of obstructive lung disease care for adults in the United States as measured by adherence to recommended processes. Chest. 2006;130(6):1844–1850. DOI:10.1378/chest.130.6.1844
- Ancochea J, Miravitlles M, Garcia-Rio F, et al. Underdiagnosis of chronic obstructive pulmonary disease in women: quantification of the problem, determinants and proposed actions. Arch Bronconeumol. 2013;49(6):223–229. DOI:10.1016/j.arbres.2012.11.010
- Capozzolo A, Castellana G, Dragonieri S, et al. Voluntary lung function screening to reveal new COPD cases in Southern Italy. Int J Chron Obstruct Pulmon Dis. 2017;12:2035–2042. DOI:10.2147/COPD.S136357
- Takahashi T, Ichinose M, Inoue H, et al. Underdiagnosis and undertreatment of COPD in primary care settings. Respirology. 2003;8(4):504–508. DOI:10.1046/j.1440-1843.2003.00501.x
- Jaen-Moreno MJ, Feu N, Del Pozo GI, et al. Chronic obstructive pulmonary disease in severe mental illness: a timely diagnosis to advance the process of quitting smoking. Eur Psychiatry. 2021;64(1):e22.
- Friend N, Hughes J, Kisely S, et al. Appraisal of physical health guidelines for severe mental illness. Aust Health Rev. 2020;44(6):904–915. DOI:10.1071/AH20080
- McGinty EE, Baller J, Azrin ST, et al. Quality of medical care for persons with serious mental illness: a comprehensive review. Schizophr Res. 2015;165(2–3):227–235. DOI:10.1016/j.schres.2015.04.010
- Lawrence D, Kisely S. Inequalities in healthcare provision for people with severe mental illness. J Psychopharmacol. 2010;24(4):61–68. DOI:10.1177/1359786810382058